Find a Tender
complete
Official procurement procedure
Supply of Pre-Prepared Radiopharmaceuticals
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Great Western Hospitals NHS Foundation Trust: "Supply of Pre-Prepared Radiopharmaceuticals". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Great Western Hospitals NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Great Western Hospitals NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Great Western Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
11Bids / Report
Supplier ConcentrationHigh Concentration
UNIVERSITY HOSPITALS BRISTOL AND WESTON NHS FOUNDATION TRUSTTop vendor: 100% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 35 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| UNIVERSITY HOSPITALS BRISTOL AND WESTON NHS FOUNDATION TRUST | 2 wins | £174,407 |
Procedure terms
Contracting AuthorityGreat Western Hospitals NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published28 Apr 2025, 09:54 BST | Last source update28 Apr 2025, 09:54 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-050810 | ||
What is being bought
Supply and daily delivery of Pre-Prepared Radiopharmaceutical Kits used in Nuclear Medicine Diagnostics. The service is critical to the delivery of time-sensitive diagnostic procedures, particularly those related to cancer pathways. Due to the nature of the product - radioactive isotopes with rapid decay - the supply is geographically restricted and must adhere to extremely tight production and delivery timelines. Kits must be delivered to the Trust by 7:00 am each day, with no shelf life available, requiring a fresh supply every 24 hours to maintain operational continuity.
What changed
From the official release history
- Status changed to complete
28 Apr 2025, 09:54 BST - Official notice release published
28 Apr 2025, 09:54 BST - Buyer information updated
28 Apr 2025, 09:54 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
28 Apr 2025, 09:54 BST - Award pending
Not published · £56,163
Commercial outcome and competition
Awards University Hospitals Bristol and Weston NHS Foundation Trust £56,163 · Not published · pending |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Great Western Hospitals NHS Foundation Trust
Contracting authority GB-PPON-PRZJ-5573-LWLPAward and contract changes
Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe preparation of radiopharmaceutical kits is regulated under the terms of the Medicines Act 1968, and the activity must be carried out by a provider licensed by the Medicines Regulatory Agency under a ‘Specials’ license. Due to the short half-life and expiry of radiopharmaceutical kits, the providers holding ‘Specials’ licenses are limited to NHS licensed providers, which are generally acute Trusts with large Nuclear Medicine Department within a 2 hour distance from the contracting Trust. Great Western Hospitals NHS Foundation Trust ("GWH") awarded a contract under Regulation 32(2)(b)(ii), to University Hospitals Bristol & Weston NHS Foundation Trust (hereafter referred to as "UHBW") in respect of the Supply of Pre-Prepared Radiopharmaceutical Kits, for a period of one (1) year, with no option to extend. This is to maintain continuation of the Nuclear Medicine service delivery for patients both currently receiving and due to receive treatment and/or diagnostics at GWH. This will also align this contract with a similar contract at Salisbury NHS Foundation Trust for the Supply of Pre-Prepared Radiopharmaceutical Kits, provided by University Hospital Southampton NHS Foundation Trust. UHBW is the incumbent supplier for Pre-Prepared Radiopharmaceutical Kits at GWH and the new contract will ensure that the current service is maintained until the time a re-tender is required, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following: Trust Turnaround Times and Patient Care: Variations in turnaround time for the delivery of these kits, while new systems for ordering, receipting and payment are set up. Currently UHBW routes for the supply of Pre-Prepared Radiopharmaceutical Kits are established and consistent, with adequate governance surrounding Data Protection in place. Risking this could lead to increased turnaround times for the delivery of these kits, and kits being unnecessarily disposed of if an unsuitable level of radioactive decay has occurred. Furthermore, if a contract is not awarded to the contracting authorities' incumbent supplier, no other provider is currently able or willing to provide this service. Packaging and Transport: New routes of transport for Pharmaceuticals would have to be set up. This would create uncertainties for both the Trust and the patients that existing processes could be upheld, including delivery times, delivery windows, care for packaging and prevention of breakages. Packaging requirements may also vary, leading to additional costs of purchase, and increased time to carry out alternative packaging requirements. Accreditation: A supplier of Radiopharmaceuticals would need to possess an appropriate license granted by the MHRA to enable them to supply radioisotopes, either in the form of a Manufacturers/importers License (MIA license) or a Manufacturer ‘specials’ licence (MS License). The time required to adequately review an alternative provider would further delay this process leading to a drop in patient care whilst Radiopharmaceutical Kits could not be obtained.: GWH has reviewed the factors described and considers that for the technical reasons listed, awarding to UHBW is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until a re-tender can be undertaken. The requirement covers the provision of the following radiopharmaceuticals: Tc99m (Technetium), MAA, HDP/HMDP, MAG3, DMSA, SESTAMIBI, NANOCOLLOID and PERTECHNETATE. These are provided in the form of multi injection vials. |